Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights
Enrollment continues in Phase 1 dose-escalation IMMUNICY-1 trial for lead shRNA-based allogeneic CAR T candidate,…
News
LianBio to Participate in the Bank of America Securities 2022 Healthcare Conference
SHANGHAI, China and PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a…
T2 Biosystems Announces First Quarter 2022 Financial Results
Results driven by strong sepsis-focused instrument placements in the United States LEXINGTON, Mass., May 05,…
Akoya Reports First Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance
Q1 2022 revenue $16.9 million, 38% growth over prior year periodRaising FY 2022 revenue guidance…
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
Corvus to Host R & D Symposium on May 10 BURLINGAME, Calif., May 05, 2022…
Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update
— Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine…
NextCure Provides Business Update and Reports First Quarter 2022 Financial Results
On track to report data from all three clinical programs in the second half of…
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results
Phase 1 data for LP352, a potential treatment for seizures associated with a broad range…
SIGA Reports Financial Results for Three Months Ended March 31, 2022
– First Sale of Intravenous (IV) TPOXX® to U.S. Government under the 19C BARDA Contract…
Windtree Therapeutics Reports First Quarter 2022 Financial Results and Provides Key Business Updates
Announced positive topline results from Phase 2 SEISMiC study of istaroxime in early cardiogenic shock Late-breaker…
Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
Initiated the fulvestrant combination arm of the first-in-human trial for RLY-2608, a pan-mutant and isoform-selective…
Organogenesis Appoints Michele Korfin and Gilberto Quintero, Ph.D. to Board of Directors
CANTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Sylogist to Discuss Performance for Q2 of Fiscal 2022
Calgary, Alberta–(Newsfile Corp. – May 5, 2022) – Sylogist Ltd. (TSX: SYZ) (“Sylogist” or the…
Steam Exchange Partners with Sheridan College Students to Help Build An Open-World Educational Metaverse Focused on Digital Assets
Toronto, Ontario–(Newsfile Corp. – May 5, 2022) – Steam Exchange, a homegrown Canadian cryptocurrency start-up,…
Microvast Schedules First Quarter Earnings Call
STAFFORD, Texas–(BUSINESS WIRE)–Microvast Holdings, Inc. (NASDAQ:MVST) (“Microvast” or the “Company”), a technology innovator that designs,…
Maranon Announces Additions to Investment and Portfolio Team
CHICAGO–(BUSINESS WIRE)–Maranon Capital, L.P. (“Maranon”) announced today the addition of Daniel P. Lewis to the…
UPDATE — Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) — Certain immaterial corrections have been made to…
RVL Pharmaceuticals plc to Discuss First Quarter 2022 Financial Results and Provide Commercial Update
Conference call to be held Thursday, May 12, 2022, at 8:30 a.m. ET BRIDGEWATER, N.J.,…
Oxurion to Participate in Upcoming Conferences
Leuven, BELGIUM, Boston, MA, US – MAY 5, 2022 – Oxurion NV (Euronext Brussels: OXUR)…
ORYZON Reports Results and Corporate Update for Quarter Ended March 31, 2022
Oryzon invests $4.2 million in R&D in the first quarter 2022 MADRID, Spain and CAMBRIDGE,…